10 research outputs found
New Candidate Predisposition Genes for Hereditary Breast Cancer: SLIT3, CREB3, USP39
Breast cancer is the most common type of malignant neoplasm in women. BRCA1 and BRCA2 are the most commonly mutated genes, but only up to 30% of hereditary breast cancer cases are attributed to alterations in these genes. A large proportion of genetic causes of hereditary breast cancer remains unknown. Thus, the search for new hereditary mutations and establishing a genetic alteration in each case of hereditary breast cancer is a clinically significant task; be the goal of our research. Next-generation sequencing (NGS) allows for simultaneous analysis of hundreds to thousands of genes at one time. We analyzed the genetic material of 49 patients of the northwest Russian population with clinical signs of hereditary breast cancer and identified new mutations associated with hereditary breast cancer. Research results show two missense mutations - SLIT3 p.Arg154Cys, CREB3 p.Lys157Glu, and truncating mutation - USP39 c.*208G>C. Research conclusion; The identified mutations can explain only a tiny fraction of hereditary breast cancer cases (0.7% to 1.1%). The next step to increase the practical value of the detected alterations should be the analysis of biological characteristics of tumors in carriers of these mutations that can potentially become a target for chemotherapy
Chick Chorioallantoic Membrane as a Patient-Derived Xenograft Model for Uveal Melanoma : Imaging Modalities for Growth and Vascular Evaluation
Background: Patient-derived tumor xenografts (PDXs) have emerged as valuable preclinical
in vivo models in oncology as they largely retain the polygenomic architecture of the human tumors
from which they originate. Although animal models are accompanied by cost and time constraints
and a low engraftment rate, PDXs have primarily been established in immunodeficient rodent models
for the in vivo assessment of tumor characteristics and of novel therapeutic cancer targets. The chick
chorioallantoic membrane (CAM) assay represents an attractive alternative in vivo model that has
long been used in the research of tumor biology and angiogenesis, and can overcome some of these
limitations. Methods: In this study, we reviewed different technical approaches for the establishment
and monitoring of a CAM-based uveal melanoma PDX model. Forty-six fresh tumor grafts were
acquired after enucleation from six uveal melanoma patients and were implanted onto the CAM on
ED7 with Matrigel and a ring (group 1), with Matrigel (group 2), or natively without Matrigel or a ring
(group 3). Real-time imaging techniques, such as various ultrasound modalities, optical coherence
tomography, infrared imaging, and imaging analyses with Image J for tumor growth and extension, as
well as color doppler, optical coherence angiography, and fluorescein angiography for angiogenesis,
were performed on ED18 as alternative monitoring instruments. The tumor samples were excised on
ED18 for histological assessment. Results: There were no significant differences between the three
tested experimental groups regarding the length and width of the grafts during the development
period. A statistically significant increase in volume (p = 0.0007) and weight (p = 0.0216) between
ED7 and ED18 was only documented for tumor specimens of group 2. A significant correlation of the
results for the cross-sectional area, largest basal diameter, and volume was documented between the
different imaging and measurement techniques and the excised grafts. The formation of a vascular
star around the tumor and of a vascular ring on the base of the tumor was observed for the majority
of the viable developing grafts as a sign of successful engraftment. Conclusion: The establishment of
a CAM-PDX uveal melanoma model could elucidate the biological growth patterns and the efficacy
of new therapeutic options in vivo. The methodological novelty of this study, investigating different
implanting techniques and exploiting advances in real-time imaging with multiple modalities, allows precise, quantitative assessment in the field of tumor experimentation, underlying the feasibility of
CAM as an in vivo PDX model
Electrochemotherapy with Bleomycin Enhances Radiosensitivity of Uveal Melanomas: First In Vitro Results in 3D Cultures of Primary Uveal Melanoma Cell Lines
Electrochemotherapy (ECT) is emerging as a complementary treatment modality for local
tumor control in various cancer entities. Irradiation is an established therapeutic option for oncologic
patients, which is commonly combined with chemotherapy due to its insufficient targeting ability.
The efficiency of radiotherapy for tumors can be enhanced with different radiosensitizers. ECT can
potentiate the radiosensitizing effect of chemotherapeutic agents such as bleomycin. The present
study aims to evaluate the radiosensitizing effect of concomitant ECT with bleomycin on 3D tumor
spheroids with primary and radioresistant uveal melanoma cell lines (UPMD2, UPMM3, UM92.1,
Mel270) and irradiation. The changes in the spheroid growth and the cell viability as well the
cytotoxic long-term effect of the combination treatment were evaluated with various combinations
of electroporation settings and bleomycin concentrations as well as radiotherapy doses. A broad
range of radiosensitivity was documented among the spheroids from different uveal melanoma cell
lines. The primary cell lines showed a higher radiosensitivity and required lower irradiation and
bleomycin doses. The maximal tumor control with a reduction of cell survival <10% was achieved
with a 5 Gy irradiation only in the primary uveal melanoma cell lines and in combination with all
tested ECT settings, whereas the same result could be obtained in UM92.1 spheroids only after ECT
with 20 Gy irradiation. Based on the spheroid growth and the measurement of the cross-sectional
area, the Mel270 spheroids, originating from a previously irradiated recurrent uveal melanoma,
required higher doses of bleomycin and ECT settings after irradiation with 5 Gy in order to achieve a
significant growth reduction. No significant difference could be demonstrated for the reduction of cell
viability in the combination therapy with 20 Gy and 1000 V/cm between 1 and 2.5 µg/mL bleomycin even in Mel270 spheroids, underlying the importance of a drug delivery system to potentiate the
radiosensitizing effect of agents in lower doses. ECT should be further assessed for its applicability
in clinical settings as a therapeutic radiosensitizing option for radioresistant tumors and a sufficient
local tumor control with lower chemotherapy and irradiation doses
Optimisation of the Chicken Chorioallantoic Membrane Assay in Uveal Melanoma Research
The treatment of uveal melanoma and its metastases has not evolved sufficiently over
the last decades in comparison to other tumour entities, posing a great challenge in the field of
ocular oncology. Despite improvements in the conventional treatment regime and new discoveries
about the genetic and molecular background of the primary tumour, effective treatment strategies to
either prevent tumours or treat patients with advanced or metastatic disease are still lacking. New
therapeutic options are necessary in order to achieve satisfactory local tumour control, reduce the
risk of metastasis development, and preserve the eyeball and possibly the visual function of the eye.
The development of in vivo model systems remains crucial for the identification and investigation of
potential novel treatment modalities. The aim of this study was the optimisation of the chorioallantoic
membrane (CAM) model for uveal melanoma research. We analysed the established CAM assay
and its modification after the implantation of three-dimensional spheroids. The chorioallantoic
membrane of a chick embryo was used to implant uveal melanoma-cell-line-derived spheroids in
order to study their growth rate, angiogenic potential, and metastatic capability. Using the UM 92.1,
UPMD2, UPMM3, and Mel270 cell lines, we were able to improve the viability of the embryos from
20% to >80% and to achieve up to a fourfold volume increase of the transplanted spheroid masses.
The results point to the value of an optimised chicken embryo assay as an in vivo model for testing
novel therapies for uveal melanoma by simplifying the research conditions and by contributing to a
considerable reduction in animal experiments
HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan
Abstract Background Human papillomavirus (HPV) is an important etiologic factor in different cancers of anogenital region and also in a fraction of head and neck cancers (HNC) particularly oropharyngeal tumors. The HPV16 genotype associated with the majority of HPV-related head and neck carcinomas. Th incidence of oropharyngeal cancer is increasing in many countries, and the rate of HPV positive tumors is about 70% in Europe and North America. Little known about the prevalence of HPV in HNC in Central Asia. Methods It’s a prospective analysis of patients with verified oral or oropharyngeal cancer. Sociodemographic and clinical data obtained on admission to treatment. The diagnosis of HPV positivity assessed by both the P16 expression on immunohistochemistry(IHC) and polymerase chain reaction (PCR)with HPV DNA detection and HR HPV type determination. Results Seventy six patients with oral and oropharyngeal cancer tested for HPV. Forteen cases were positive for HPV by PCR and 15 cases by P16 IHC. Of the 35 oropharyngeal tumors, nine were HPV DNA and p16 IHC positive, giving the rate of 25.7%. Of the 41 oral tumors, five were HPV DNA and six p16 IHC positive, giving the rate of 12.2%. Conclusion It is the first study mapping prevalence of HPV positivity in oral and oropharyngeal cancer in the Central Asian region. The rate of HPV positivity was higher in oropharyngeal than in oral cancer, the nonsmokers were significantly more frequent in the HPV positive group and HPV 16 was the most frequent type. However, the HPV positivity rates are lower than referred in the western world
Cystic Echinococcosis of the Bone in Kazakhstan
Cystic echinococcosis (CE) is a parasitic zoonosis caused by E. granulosus primarily affecting the liver and lungs. CE of the bone is by far the most debilitating form of the disease and is very difficult to manage as it mimics malignant tumors. We reviewed bone CE cases admitted to a reference oncological hospital in Kazakhstan from January 2010 to February 2017. Among eight patients, the mean age was 33.5 years, and the male/female ratio was 1 : 3. Patients were examined by X-ray (8/8), CT (7/8), and MRI (3/8). CE was in the spine (2 cases), pelvis (3 cases), and long bones (humerus, tibia, and femur; one case for each). All patients were treated surgically. No perioperative albendazole was administered. No patient received albendazole afterwards. The mean hospital stay was 25 days. Interventions are urgently needed to assess the burden of CE in Kazakhstan and to inform clinicians of the existence of the disease
Optimisation of the Chicken Chorioallantoic Membrane Assay in Uveal Melanoma Research
The treatment of uveal melanoma and its metastases has not evolved sufficiently over the last decades in comparison to other tumour entities, posing a great challenge in the field of ocular oncology. Despite improvements in the conventional treatment regime and new discoveries about the genetic and molecular background of the primary tumour, effective treatment strategies to either prevent tumours or treat patients with advanced or metastatic disease are still lacking. New therapeutic options are necessary in order to achieve satisfactory local tumour control, reduce the risk of metastasis development, and preserve the eyeball and possibly the visual function of the eye. The development of in vivo model systems remains crucial for the identification and investigation of potential novel treatment modalities. The aim of this study was the optimisation of the chorioallantoic membrane (CAM) model for uveal melanoma research. We analysed the established CAM assay and its modification after the implantation of three-dimensional spheroids. The chorioallantoic membrane of a chick embryo was used to implant uveal melanoma-cell-line-derived spheroids in order to study their growth rate, angiogenic potential, and metastatic capability. Using the UM 92.1, UPMD2, UPMM3, and Mel270 cell lines, we were able to improve the viability of the embryos from 20% to >80% and to achieve up to a fourfold volume increase of the transplanted spheroid masses. The results point to the value of an optimised chicken embryo assay as an in vivo model for testing novel therapies for uveal melanoma by simplifying the research conditions and by contributing to a considerable reduction in animal experiments